Zantac Study Finds Gastrointestinal Cancer Risk Three Times Higher Among Users of Recalled Heartburn Drug
A new study links NDMA found in Zantac to a higher risk of gastrointestinal cancers than other heartburn drugs.…
«
»
A new study links NDMA found in Zantac to a higher risk of gastrointestinal cancers than other heartburn drugs.…
Three drug manufacturers are calling for a Belviq class action lawsuit to be dismissed, saying the charges are not applicable under New York laws.…
Bariatric surgery may decrease the risk of colorectal cancer, according to the findings of a new study.…
A class action lawsuit filed against the makers of Belviq claim they knew about the cancer risks of the recalled weight loss drug before it even hit the market.…
Zantac NDMA exposure led to a colorectal cancer diagnosis, a Kentucky woman’s lawsuit claims.…
Thousands of Belviq users face an increased cancer risk due to the side effects of the recalled weight loss drug.…
In February 2020, the weight loss drug Belviq was removed from the market, amid concerns that side effects may increase the risk of cancer. Lawsuits and class action claims are now being pursued by former users throughout the United States.…
Belviq cancer concerns arose before the weight loss drug was even approved, but it never carried a cancer warning label.…
A Zantac lawsuit filed by a Kentucky man says he developed colorectal cancer due to exposure to NDMA in Zantac tablets over nine years of use, which has now spread to his liver.…
A new study reveals that many young patients receive a cancer misdiagnosis, which prevents them from getting proper early treatment for colorectal cancer.…